News

Johnson & Johnson Seeks FDA Authorization For COVID-19 Vaccine Booster Shots

On Tuesday, Johnson & Johnson petitioned the U.S. Food and Drug Administration (FDA) to authorize a booster shot of its COVID-19 vaccine.

J&J had previously revealed an internal study Monday that showed a second shot administered two months after the first shot improved immunity against symptomatic moderate to severe symptoms to COVID to 94 percent.

“A booster of our COVID-19 vaccine increases levels of protection for those who have received our single-shot vaccine to 94 percent,” said Mathai Mammen, who’s in charge of the global R&D division at J&J’s Janssen. “At the same time, we continue to recognize that a single-shot COVID-19 vaccine that provides strong and long-lasting protection remains a crucial component to vaccinating the global population.”

As the pharmaceutical company submitted its petition, the FDA’s independent vaccine advisory committee is set to meet on Oct. 15 to discuss whether to recommend the booster shot from J&J to the federal agency.

Subscribe to our free weekly newsletter!

A week of political news in your in-box.
We find the news you need to know, so you don't have to.

J&J’s single-dose vaccine has experienced several problems since FDA gave the Emergency Use Authorization to the company.

In April, the J&J vaccine was paused over rare blood clotting symptoms shown by dozens of women who got the single shot. The production was also disrupted for months due to the mistakes made by the Baltimore manufacturing plant.

On Tuesday, the Public Health Insider reported that another woman in her late 30s died from blood clotting symptoms last month after she was given a J&J shot.

“We at Public Health are saddened by this loss and offer condolences to the woman’s family and loved ones. The resident received her vaccination on August 26, 2021 and died on September 7, 2021. Her cause of death was determined to be thrombosis with thrombocytopenia syndrome (TTS), a condition that has been identified as a rare but potentially serious adverse event in people who received the J&J vaccine. The diagnosis was confirmed by the CDC’s Clinical Immunization Safety Assessment Project,” the statement read.

Dongyoon Shin

Recent Posts

VIDEO: Trump Watches SpaceX Launch Alongside Elon Musk & Ted Cruz

https://youtube.com/shorts/YVrfbMZSVRE?feature=share US President-elect Donald Trump drew cheers as he arrived in Texas on Nov. 19 to watch…

2 days ago

Foreign Policy Experts Voice Concern About Trump’s Nomination Of Tulsi Gabbard For Director Of National Intelligence

After President-elect Donald Trump selected Tulsi Gabbard, a former Democratic congresswoman, as his nominee for…

3 days ago

Trump’s Pick Of Vaccine-Skeptic Robert F. Kennedy Jr. As Department of Health & Human Services Secretary Alarms Scientific Community

President-elect Donald Trump's announcement that Robert F. Kennedy Jr. will be his pick for Department…

4 days ago

VIDEO: President-Elect Donald Trump, Elon Musk & Cabinet Picks Attend UFC Fight In NYC, Crowd Chants “USA”

https://youtube.com/shorts/6CUvTmS87UM?feature=share President-elect Donald Trump arrived to cheers at an Ultimate Fighting Championship (UFC) event in…

4 days ago

Trump Pick Of Matt Gaetz For Attorney General Sends Shock Waves Through Capitol

President-elect Donald Trump's nomination of former Rep. Matt Gaetz (R-Florida) as his attorney general has sent shockwaves through…

5 days ago

VIDEO: Fights Break Out In Stand During France-Israel Match

https://youtube.com/shorts/TD8RNJl-NBk A fight broke out in one of the stands at the Stade de France…

5 days ago